{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:29:25Z","timestamp":1790126965488,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012634","name":"Novocure","doi-asserted-by":"crossref","award":["NCT00916409"],"award-info":[{"award-number":["NCT00916409"]}],"id":[{"id":"10.13039\/100012634","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11060-017-2601-y","type":"journal-article","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T09:01:34Z","timestamp":1503910894000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma"],"prefix":"10.1007","volume":"135","author":[{"name":"Zvi Ram on behalf of the EF-14 Trial Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4635-0914","authenticated-orcid":false,"given":"Jay-Jiguang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petya","family":"Demireva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Kanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Pannullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Mehdorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Avgeropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salmaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Silvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Goldlust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Benouaich-Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"issue":"7","key":"2601_CR1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG et al (2014) The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol 16(7):896\u2013913","journal-title":"Neuro Oncol"},{"issue":"27","key":"2601_CR2","doi-asserted-by":"crossref","first-page":"44015","DOI":"10.18632\/oncotarget.17054","volume":"8","author":"P Zhu","year":"2017","unstructured":"Zhu P, Du XL, Lu G, Zhu JJ (2017) Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: a population-based study. Oncotarget 8(27):44015\u201344031","journal-title":"Oncotarget"},{"key":"2601_CR3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"issue":"5","key":"2601_CR4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466","journal-title":"Lancet Oncol"},{"issue":"6","key":"2601_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/neuonc\/nor065","volume":"13","author":"M Weller","year":"2011","unstructured":"Weller M (2011) Neurocognitive function: an emerging surrogate endpoint for neuro-oncology trials. Neuro Oncol 13(6):565","journal-title":"Neuro Oncol"},{"key":"2601_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1215\/15228517-2008-050","volume":"11","author":"JX Cheng","year":"2009","unstructured":"Cheng JX, Zhang X, Liu BL (2009) Health-related quality of life in patients with high-grade glioma. Neuro Oncol 11:41\u201350","journal-title":"Neuro Oncol"},{"issue":"2","key":"2601_CR7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/089198878900200209","volume":"2","author":"EJ Warren","year":"1989","unstructured":"Warren EJ, Grek A, Conn D et al (1989) correlation between cognitive performance and daily functioning in elderly people. J Geriatr Psychiatry Neurol 2(2):96\u2013100","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2601_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/neuonc\/5.2.89","volume":"5","author":"CA Meyers","year":"2003","unstructured":"Meyers CA, Hess KR (2003) Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol 5:89\u201395","journal-title":"Neuro Oncol"},{"issue":"3","key":"2601_CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11060-011-0565-x","volume":"104","author":"R Henriksson","year":"2011","unstructured":"Henriksson R, Asklund T, Poulsen HS (2011) Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 104(3):639\u2013646","journal-title":"J Neurooncol"},{"key":"2601_CR10","unstructured":"Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Central Nervous System Cancers. Cancer Guidelines. 2016"},{"key":"2601_CR11","doi-asserted-by":"crossref","first-page":"18046","DOI":"10.1038\/srep18046","volume":"5","author":"M Giladi","year":"2015","unstructured":"Giladi M, Schneiderman RS, Voloshin T et al (2015) Mitotic spindle disruption by alternating electric fields leads to improper chromosome segregation and mitotic catastrophe in cancer cells. Sci Rep 5:18046","journal-title":"Sci Rep"},{"issue":"5","key":"2601_CR12","doi-asserted-by":"crossref","first-page":"e0125269","DOI":"10.1371\/journal.pone.0125269","volume":"10","author":"N Gera","year":"2015","unstructured":"Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD (2015) Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS ONE 10(5):e0125269","journal-title":"PLoS ONE"},{"key":"2601_CR13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejca.2012.04.011","volume":"48","author":"R Stupp","year":"2012","unstructured":"Stupp R, Wong ET, Kanner AA et al (2012) NovoTTF-100A versus physician\u2019s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Euro J Cancer 48:292\u20132202","journal-title":"Euro J Cancer"},{"issue":"23","key":"2601_CR14","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp R, Taillibert S, Kanner AA et al (2015) Maintenance therapy with tumor-treating fields plus temozolomide vs. temozolomide alone for glioblastoma. JAMA 314(23):2535\u20132543","journal-title":"JAMA"},{"key":"2601_CR15","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdq726","volume":"9","author":"J Maringwa","year":"2011","unstructured":"Maringwa J, Quinten C, King M et al (2011) Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol 9:2107\u20132112","journal-title":"Ann Oncol"},{"key":"2601_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"issue":"5","key":"2601_CR17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"key":"2601_CR18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ejca.2010.01.012","volume":"46","author":"MJ Taphoorn","year":"2010","unstructured":"Taphoorn MJ, Claassens L, Aaronson NK et al (2010) An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J of Cancer 46:1033\u20131040","journal-title":"Eur J of Cancer"},{"key":"2601_CR19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0959-8049(01)00127-7","volume":"37","author":"PM Fayers","year":"2001","unstructured":"Fayers PM (2001) Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 37:1331\u20131334","journal-title":"Eur J Cancer"},{"issue":"9","key":"2601_CR20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40(9):922\u2013935","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"2601_CR21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archneur.65.7.963","volume":"65","author":"SE O\u2019Bryant","year":"2008","unstructured":"O\u2019Bryant SE, Humphreys JD, Smith GE et al (2008) Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol 65(7):963\u2013967","journal-title":"Arch Neurol"},{"key":"2601_CR22","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1200\/JCO.2003.07.080","volume":"21","author":"CA Meyers","year":"2003","unstructured":"Meyers CA, Wefel JS (2003) The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557\u20133558","journal-title":"J Clin Oncol"},{"issue":"2","key":"2601_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11060-009-9923-3","volume":"95","author":"BW Corn","year":"2009","unstructured":"Corn BW, Wang M, Fox S et al (2009) Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. J Neurooncol 95(2):247\u2013257","journal-title":"J Neurooncol"},{"issue":"1","key":"2601_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-013-1159-6","volume":"114","author":"K Reddy","year":"2013","unstructured":"Reddy K, Gaspar LE, Kavanagh BD et al (2013) Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol 114(1):111\u2013116","journal-title":"J Neurooncol"},{"issue":"21","key":"2601_CR25","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMc1402987","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL, Wick W, Cloughesy T (2014) Bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370(21):2049","journal-title":"N Engl J Med"},{"key":"2601_CR26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1470-2045(10)70294-1","volume":"12","author":"JS Wefel","year":"2011","unstructured":"Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonies studies of cognitive function in patients with cancer. Lancet Oncol 12:703\u2013708","journal-title":"Lancet Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2601-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2601-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2601-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T20:45:06Z","timestamp":1659386706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2601-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2601"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2601-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,28]]}}}